查看购物车
  • Traditional Chinese
  • English
封面
市场调查报告书
商品编码
1634212

全球 PEEK 椎间器材市场 - 2025 - 2033

Global PEEK Interbody Devices Market - 2025 - 2033
出版日期: | 出版商: DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球PEEK椎间器械市场规模达25亿美元，预计2033年将达到46亿美元，2025-2033年预测期间复合年增长率为7.4%。

PEEK（聚醚醚酮）椎间装置是由高性能热塑性聚合物製成的医疗植入物，专为脊椎手术而设计。这些装置主要用于脊椎融合手术，透过取代受损或退化的椎间盘并促进相邻椎骨的融合来帮助稳定脊椎。 PEEK 是一种生物相容性聚合物，以其优异的机械性能而闻名，包括高强度、刚度以及耐磨性和耐降解性。

PEEK 椎间融合器最常用于前路颈椎间盘切除融合术(ACDF)、腰椎椎间融合术(LIF)、后路腰椎椎间融合术(PLIF) 和经椎间孔腰椎椎间融合术(TLIF ) 手术。它们的目的是在癒合和融合过程中提供长期支持。

由于脊椎手术的进步、不断增长的医疗保健需求以及 PEEK 作为经过科学分析的材料的独特优势，多年来，PEEK（聚醚醚酮）椎间器械的市场需求一直在稳步增长。例如，根据美国国立卫生研究院(NIH) 的数据，最终分析纳入了5 项使用PEEK 椎间装置的研究（146 名患者），其中包括1 项随机对照试验、2 项前瞻性研究和2 项回顾性研究。这 5 项研究中 PEEK 椎间装置的融合率为 88% 至 98%。

市场动态：

驱动程式和限制

PEEK 椎间器械不断进步的技术

PEEK 椎间设备不断进步的技术进步极大地推动了市场的成长，预计将在预测期内推动市场的发展。这些进步提高了 PEEK 植入物的性能、客製化和多功能性，使其成为脊椎手术的首选。使用 3D 列印（积层製造）技术可以创建适合患者独特脊椎解剖结构的个人化 PEEK 椎间设备。这提高了手术的准确性，减少了併发症，并提高了成功融合的机会。

例如，2024 年 6 月，领先的技术和製造公司 Curiteva, Inc. 在其经 FDA 批准的 Inspire Posterior Interbody Fusion Solutions 中推出了众多产品中的第一个产品。这款采用 HAFUSE 技术的 3D 列印小梁 PEEK 椎间体专为提高经椎间孔腰椎手术的患者治疗效果而开发，拥有优化的互连多孔结构，可促进骨骼向内生长并穿过整个装置。

PEEK 的射线可透特性允许在手术后进行清晰的 X 光和 CT 扫描，这对于在不受金属植入物干扰的情况下监测癒合过程至关重要。这比传统的钛植入物具有优势，特别是对于长期监测。恢復期间和术后护理期间对精确监测的需求不断增长，推动了 PEEK 植入物市场的成长。外科医生更喜欢 PEEK，因为它能够实现更好的成像，从而提高患者满意度并减少併发症。

来自替代材料的竞争

来自替代材料的竞争是阻碍 PEEK 椎间器械市场成长的主要挑战之一。儘管 PEEK 具有许多优点，但也用于脊椎融合手术的其他材料的可用性可能会限制其市场份额。由于其优异的骨整合特性、生物相容性和支持骨骼生长的能力，钛仍然是脊椎植入物中最常用的材料之一。与 PEEK 不同，钛具有促进骨骼生长的天然粗糙表面，通常可以实现更快、更有效的脊椎融合。

钛基椎体间装置是 PEEK 植入物的直接竞争对手，特别是对于需要提高融合率的患者。这些植入物在脊椎手术中拥有良好的记录，使其成为 PEEK 的有力竞争对手。碳纤维增强 PEEK (CFR-PEEK) 装置正在作为一种替代方案出现，它结合了 PEEK 和碳纤维的优点，可改善机械性能和患者治疗效果。 CFRP 替代品在脊椎手术中的使用增加减少了对传统 PEEK 设备的市场需求。

陶瓷基底植体以其优异的生物相容性和骨整合而闻名。这些材料能够增强骨结合，并提供金属和 PEEK 植入物的替代品，特别是在脊椎融合手术中。陶瓷在促进更好的骨骼生长和减少长期植入併发症方面具有竞争优势。随着它们在医学界获得认可，它们的采用可能会减少对 PEEK 椎间设备的需求。

生物可吸收材料（例如聚-L-乳酸和其他生物可吸收聚合物）是一类在脊椎外科手术中受到关注的新型材料，因为它们随着时间的推移逐渐分解并被人体吸收。这消除了融合完成后进行植入物移除手术的需要，使它们成为对某些患者极具吸引力的替代方案。随着生物可吸收植入物在强度和性能方面的提高，它们消除对永久性脊椎植入物的需求的能力使其成为 PEEK 设备日益增长的竞争对手。

有关此报告的更多详细资讯 - 索取样品

目录

第一章：市场介绍和范围

  • 报告的目标
  • 报告范围和定义
  • 报告范围

第 2 章：高阶主管见解与要点

  • 市场亮点和战略要点
  • 主要趋势和未来预测
  • 按产品类型分類的片段
  • 最终使用者的片段
  • 按地区分類的片段

第 3 章：动力学

  • 影响因素
    • 司机
      • PEEK 椎间器械技术不断进步
    • 限制
      • 来自替代材料的竞争
    • 机会
    • 影响分析

第 4 章：策略洞察与产业展望

  • 市场领导者和先驱
    • 新兴先锋和杰出参与者
    • 拥有最大销售品牌的知名领导者
    • 拥有成熟产品的市场领导者
  • 新兴新创企业和关键创新者
  • CXO 观点
  • 最新进展和突破
  • 案例研究/正在进行的研究
  • 监管和报销情况
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲
  • 波特五力分析
  • 供应链分析
  • 专利分析
  • SWOT分析
  • 未满足的需求和差距
  • 市场进入和扩张的推荐策略
  • 情境分析：最佳情况、基本情况和最坏情况预测
  • 定价分析和价格动态

第 5 章：PEEK 椎间器械市场，依产品类型

  • 椎间融合器
  • 前路腰椎椎间融合器 (ALIF)
  • 极端横向椎间融合装置 (XLIF)
  • 后路腰椎间融合器 (PLIF)
  • 经椎间孔腰椎椎间融合器 (TLIF)
  • 其他的

第 6 章：PEEK 椎间设备市场（依最终使用者）

  • 医院
  • 专科诊所
  • 门诊手术中心
  • 其他的

第 7 章：PEEK 体内设备市场，按区域市场分析和成长机会

  • 北美洲
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 西班牙
    • 义大利
    • 欧洲其他地区
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地区
  • 亚太
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 中东和非洲

第 8 章：竞争格局与市场定位

  • 竞争概况和主要市场参与者
  • 市占率分析与定位矩阵
  • 策略伙伴关係、併购
  • 产品组合和创新的主要发展
  • 公司基准化分析

第 9 章：公司简介

  • Stryker Corporation
    • 公司概况
    • 产品组合和描述
    • 财务概览
    • 主要进展
    • SWOT分析
  • Globus Medical, Inc.
  • B. Braun SE
  • Xtant Medical
  • Invibio Ltd.
  • ATEC Spine, Inc
  • Life Spine, Inc.
  • Orthofix Medical Inc.
  • Curiteva, Inc.
  • Intelivation Technologies

第 10 章：假设与研究方法

  • 资料收集方法
  • 数据三角测量
  • 预测技术
  • 数据验证和确认

第 11 章：附录

简介目录
Product Code: MD9026

The global PEEK interbody devices market reached US$ 2.5 billion in 2024 and is expected to reach US$ 4.6 billion by 2033, growing at a CAGR of 7.4% during the forecast period 2025-2033.

PEEK (Polyether Ether Ketone) interbody devices are medical implants made from a high-performance thermoplastic polymer, designed specifically for use in spinal surgeries. These devices are primarily used in spinal fusion procedures, where they help stabilize the spine by replacing damaged or degenerated intervertebral discs and promoting the fusion of adjacent vertebrae. PEEK is a biocompatible polymer known for its excellent mechanical properties, including high strength, stiffness, and resistance to wear and degradation.

PEEK interbody devices are most commonly used in anterior cervical discectomy and fusion (ACDF), lumbar interbody fusion (LIF), posterior lumbar interbody fusion (PLIF) and transforaminal lumbar interbody fusion (TLIF) surgeries. They are intended to provide long-term support during the healing and fusion process.

The market demand for PEEK (Polyether Ether Ketone) interbody devices has been steadily increasing over the years due to various factors related to advancements in spinal surgery, growing healthcare needs, and the unique benefits of PEEK as a material with scientific analysis. For instance, according to the National Institute of Health (NIH), five studies using PEEK interbody devices (146 patients) were included in the final analysis, including 1 randomized controlled trial, 2 prospective studies, and 2 retrospective studies. Rates of fusion for PEEK interbody devices in these 5 studies were 88% to 98%.

Market Dynamics: Drivers & Restraints

Rising technological advancements in PEEK interbody devices

The rising technological advancements in PEEK interbody devices are significantly driving the growth of the market and are expected to drive the market over the forecast period. These advancements are enhancing the performance, customization, and versatility of PEEK implants, making them a preferred choice in spinal surgeries. The use of 3D printing (additive manufacturing) technology allows for the creation of personalized PEEK interbody devices tailored to a patient's unique spinal anatomy. This improves the accuracy of surgeries, reduces complications, and enhances the chances of successful fusion.

For instance, in June 2024, Curiteva, Inc., a leading technology and manufacturing company, commercially launched the first of many offerings in its FDA-cleared Inspire Posterior Interbody Fusion Solutions. Developed to enhance patient outcomes of transforaminal lumbar procedures, this 3D Printed Trabecular PEEK with HAFUSE Technology interbody boasts an optimized interconnected porous structure, promoting bone ingrowth into and through the entire device.

PEEK's radiolucent properties allow for clear X-ray and CT scans post-surgery, which is crucial for monitoring the healing process without interference from metallic implants. This provides an advantage over traditional titanium implants, particularly for long-term monitoring. The increasing demand for precise monitoring during recovery and post-operative care is pushing the growth of PEEK implants in the market. Surgeons prefer PEEK for its ability to allow for better imaging, leading to greater patient satisfaction and fewer complications.

Competition from alternative materials

Competition from alternative materials is one of the key challenges hampering the growth of the PEEK interbody devices market. Although PEEK offers many advantages, the availability of other materials that are also used for spinal fusion surgeries can limit its market share. Titanium remains one of the most commonly used materials in spinal implants due to its superior osseointegration properties, biocompatibility, and ability to support bone growth. Unlike PEEK, titanium has natural rough surfaces that encourage bone growth, often leading to quicker and more effective spinal fusion.

Titanium-based interbody devices are a direct competitor to PEEK implants, particularly for patients who require enhanced fusion rates. These implants have a proven track record in spinal surgeries, making them a strong competitor for PEEK. Carbon fiber-reinforced PEEK (CFR-PEEK) devices are emerging as an alternative, combining the benefits of PEEK and carbon fiber for improved mechanical properties and patient outcomes. This increased use of CFRP alternatives in spinal surgeries reduces the market demand for traditional PEEK devices.

Ceramic-based implants are known for their excellent biocompatibility and osseointegration. These materials offer the ability to enhance bone bonding and provide an alternative to both metal and PEEK implants, particularly in spinal fusion surgeries. Ceramics offer a competitive edge in terms of promoting better bone growth and reducing long-term implant complications. As they gain recognition in the medical community, their adoption may reduce demand for PEEK interbody devices.

Bioresorbable materials (such as poly-L-lactic acid and other bioabsorbable polymers) are a new class of materials gaining attention in spinal surgery because they gradually break down and are absorbed by the body over time. This eliminates the need for implant removal surgery after fusion is complete, making them a highly attractive alternative for some patients. As bioresorbable implants improve in terms of strength and performance, their ability to eliminate the need for permanent spinal implants positions them as a growing competitor to PEEK devices.

For more details on this report - Request for Sample

Segment Analysis

The global PEEK interbody devices market is segmented based on product type, end-user and region.

Product Type:

The posterior lumbar interbody fusion devices segment is expected to dominate the PEEK interbody devices market share

One of the most notable benefits of using PEEK in posterior lumbar interbody fusion (PLIF) surgeries is its radiolucency. PEEK allows for clear post-surgical imaging (X-rays, CT scans), enabling better monitoring of the healing process without interference from the implant. This is particularly valuable in PLIF, where precise imaging is crucial to ensure the fusion process is proceeding correctly.

The adoption of minimally invasive spine surgery techniques, including minimally invasive PLIF (MIS-PLIF), is growing globally, especially in developed regions like the U.S. and Europe. PEEK's compatibility with minimally invasive spine surgery, due to its precise fit and ease of use, is fueling its dominance in posterior lumbar interbody fusion surgeries.

The growing preference for minimally invasive procedures, which involve smaller incisions and quicker recovery times, is driving the demand for PEEK interbody devices, particularly in PLIF surgeries, as they help enhance success rates and reduce surgical complications. Thus, many market players and emerging startups are focussing on the development of posterior interbody fusion devices with advanced features.

For instance, in October 2021, NuVasive, Inc., the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, launched the Cohere TLIF-O implant and the Cohere TLIF-A implant. With these additions to its Advanced Materials Science (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine surgery.

Geographical Analysis

North America is expected to hold a significant position in the PEEK interbody devices market share

North America, particularly the United States has a high incidence of degenerative disc disease, herniated discs and other spinal disorders, which drive the demand for spinal surgeries, including those using PEEK interbody devices. The aging population and lifestyle-related conditions contribute to the growing prevalence of spinal issues.

Additionally, according to the National Institute of Health (NIH), approximately 900,000 American and 30,000 Canadian adults undergo spine surgery annually. This rising number of spinal surgeries in North America especially in the United States and Canada directly boosts the demand for PEEK interbody devices, making the region the largest market for these implants.

The United States leads in the adoption of advanced surgical techniques such as minimally invasive spine surgery, which requires highly precise and biocompatible materials like PEEK. The use of PEEK interbody devices in PLIF (Posterior Lumbar Interbody Fusion) and other spinal fusion procedures is common in MISS due to its strength, radiolucency, and compatibility with modern imaging techniques.

Asia-Pacific is growing at the fastest pace in the PEEK interbody devices market

As the population in Asia-Pacific countries ages and urbanization increases, the incidence of spinal disorders such as degenerative disc disease, scoliosis, and herniated discs is rising. This has resulted in greater demand for spinal surgeries, including posterior lumbar interbody fusion (PLIF), anterior lumbar interbody fusion (ALIF), and other spinal fusion procedures that require interbody devices like PEEK. According to Clearstate, in 2022, an estimated total of 47k implanted spinal procedures were performed across SEA countries. As spinal procedures are growing in the region, many market players are expanding their spinal portfolio into PEEK interbody devices market.

For instance, in June 2022, an established strategic partnership between Beijing Fule and Invibio Biomaterial Solutions has resulted in the development of a new generation of interbody fusion devices, the first such high-performance material medical fusion cage product based upon PEEK-OPTIMATM HA Enhanced polymers in China.

Over the past decade, countries in APAC, such as India, China, Japan, and South Korea, have significantly improved their healthcare infrastructure. The adoption of advanced medical technologies like PEEK interbody devices has been a major factor in this growth. Many hospitals and surgical centers now offer world-class spine surgeries using cutting-edge technologies. APAC countries, particularly India, Thailand, and Singapore, have become global hubs for medical tourism due to cost-effective treatments combined with high-quality healthcare services. Spinal surgeries, including those using PEEK devices, are increasingly popular among medical tourists from the U.S., Europe, and the Middle East.

Competitive Landscape

The major global players in the PEEK interbody devices market include Stryker Corporation, Globus Medical, Inc., B. Braun SE, Xtant Medical, Invibio Ltd., ATEC Spine, Inc., Life Spine, Inc, Orthofix Medical Inc., Curiteva, Inc., Intelivation Technologies and among others.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global PEEK interbody devices market report delivers a detailed analysis with 54 key tables, more than 46 visually impactful figures, and 147 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Market Introduction and Scope

  • 1.1. Objectives of the Report
  • 1.2. Report Coverage & Definitions
  • 1.3. Report Scope

2. Executive Insights and Key Takeaways

  • 2.1. Market Highlights and Strategic Takeaways
  • 2.2. Key Trends and Future Projections
  • 2.3. Snippet by Product Type
  • 2.4. Snippet by End-User
  • 2.5. Snippet by Region

3. Dynamics

  • 3.1. Impacting Factors
    • 3.1.1. Drivers
      • 3.1.1.1. Rising Technological Advancements in PEEK Interbody Devices
    • 3.1.2. Restraints
      • 3.1.2.1. Competition From Alternative Materials
    • 3.1.3. Opportunity
    • 3.1.4. Impact Analysis

4. Strategic Insights and Industry Outlook

  • 4.1. Market Leaders and Pioneers
    • 4.1.1. Emerging Pioneers and Prominent Players
    • 4.1.2. Established leaders with largest selling Brand
    • 4.1.3. Market leaders with established Product
  • 4.2. Emerging Startups and Key Innovators
  • 4.3. CXO Perspectives
  • 4.4. Latest Developments and Breakthroughs
  • 4.5. Case Studies/Ongoing Research
  • 4.6. Regulatory and Reimbursement Landscape
    • 4.6.1. North America
    • 4.6.2. Europe
    • 4.6.3. Asia Pacific
    • 4.6.4. Latin America
    • 4.6.5. Middle East & Africa
  • 4.7. Porter's Five Force Analysis
  • 4.8. Supply Chain Analysis
  • 4.9. Patent Analysis
  • 4.10. SWOT Analysis
  • 4.11. Unmet Needs and Gaps
  • 4.12. Recommended Strategies for Market Entry and Expansion
  • 4.13. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 4.14. Pricing Analysis and Price Dynamics

5. PEEK Interbody Devices Market, By Product Type

  • 5.1. Introduction
    • 5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 5.1.2. Market Attractiveness Index, By Product Type
  • 5.2. Interbody Fusion Devices*
    • 5.2.1. Introduction
    • 5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 5.3. Anterior Lumbar Interbody Fusion Devices (ALIF)
  • 5.4. Extreme Lateral Interbody Fusion Devices (XLIF)
  • 5.5. Posterior Lumbar Interbody Fusion Devices (PLIF)
  • 5.6. Transforaminal Lumbar Interbody Fusion Devices (TLIF)
  • 5.7. Others

6. PEEK Interbody Devices Market, By End-User

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 6.1.2. Market Attractiveness Index, By End-User
  • 6.2. Hospitals*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Specialty Clinics
  • 6.4. Ambulatory Surgical Centers
  • 6.5. Others

7. PEEK Interbody Devices Market, By Regional Market Analysis and Growth Opportunities

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 7.1.2. Market Attractiveness Index, By Region
  • 7.2. North America
    • 7.2.1. Introduction
    • 7.2.2. Key Region-Specific Dynamics
    • 7.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.2.5.1. U.S.
      • 7.2.5.2. Canada
      • 7.2.5.3. Mexico
  • 7.3. Europe
    • 7.3.1. Introduction
    • 7.3.2. Key Region-Specific Dynamics
    • 7.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.3.5.1. Germany
      • 7.3.5.2. U.K.
      • 7.3.5.3. France
      • 7.3.5.4. Spain
      • 7.3.5.5. Italy
      • 7.3.5.6. Rest of Europe
  • 7.4. South America
    • 7.4.1. Introduction
    • 7.4.2. Key Region-Specific Dynamics
    • 7.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.4.5.1. Brazil
      • 7.4.5.2. Argentina
      • 7.4.5.3. Rest of South America
  • 7.5. Asia-Pacific
    • 7.5.1. Introduction
    • 7.5.2. Key Region-Specific Dynamics
    • 7.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 7.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 7.5.5.1. China
      • 7.5.5.2. India
      • 7.5.5.3. Japan
      • 7.5.5.4. South Korea
      • 7.5.5.5. Rest of Asia-Pacific
  • 7.6. Middle East and Africa
    • 7.6.1. Introduction
    • 7.6.2. Key Region-Specific Dynamics
    • 7.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

8. Competitive Landscape and Market Positioning

  • 8.1. Competitive Overview and Key Market Players
  • 8.2. Market Share Analysis and Positioning Matrix
  • 8.3. Strategic Partnerships, Mergers & Acquisitions
  • 8.4. Key Developments in Product Portfolios and Innovations
  • 8.5. Company Benchmarking

9. Company Profiles

  • 9.1. Stryker Corporation*
    • 9.1.1. Company Overview
    • 9.1.2. Product Portfolio and Description
    • 9.1.3. Financial Overview
    • 9.1.4. Key Developments
    • 9.1.5. SWOT Analysis
  • 9.2. Globus Medical, Inc.
  • 9.3. B. Braun SE
  • 9.4. Xtant Medical
  • 9.5. Invibio Ltd.
  • 9.6. ATEC Spine, Inc
  • 9.7. Life Spine, Inc.
  • 9.8. Orthofix Medical Inc.
  • 9.9. Curiteva, Inc.
  • 9.10. Intelivation Technologies

LIST NOT EXHAUSTIVE

10. Assumption and Research Methodology

  • 10.1. Data Collection Methods
  • 10.2. Data Triangulation
  • 10.3. Forecasting Techniques
  • 10.4. Data Verification and Validation

11. Appendix

  • 11.1. About Us and Services
  • 11.2. Contact Us